Dubuque Bank & Trust Co. acquired a new position in shares of Danaher Co. (NYSE:DHR) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,560 shares of the conglomerate’s stock, valued at approximately $225,000.
A number of other institutional investors and hedge funds also recently modified their holdings of the business. Nuveen Asset Management LLC boosted its stake in shares of Danaher by 10,853.5% in the 2nd quarter. Nuveen Asset Management LLC now owns 3,664,924 shares of the conglomerate’s stock worth $523,790,000 after buying an additional 3,631,465 shares during the last quarter. Janus Henderson Group PLC boosted its stake in shares of Danaher by 274.8% in the 2nd quarter. Janus Henderson Group PLC now owns 2,858,029 shares of the conglomerate’s stock worth $408,466,000 after buying an additional 2,095,396 shares during the last quarter. Jennison Associates LLC boosted its stake in shares of Danaher by 38.4% in the 2nd quarter. Jennison Associates LLC now owns 5,135,358 shares of the conglomerate’s stock worth $733,945,000 after buying an additional 1,424,328 shares during the last quarter. Railway Pension Investments Ltd purchased a new position in shares of Danaher in the 2nd quarter worth approximately $13,030,000. Finally, Sustainable Growth Advisers LP purchased a new position in shares of Danaher in the 2nd quarter worth approximately $124,387,000. 78.42% of the stock is owned by hedge funds and other institutional investors.
A number of brokerages have recently weighed in on DHR. Needham & Company LLC restated a “buy” rating and issued a $155.00 target price (up previously from $142.00) on shares of Danaher in a research note on Friday, July 19th. Argus upped their price objective on Danaher to $165.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. Royal Bank of Canada set a $134.00 price objective on Danaher and gave the company a “hold” rating in a research note on Friday, July 19th. Piper Jaffray Companies upped their price objective on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research note on Thursday, July 18th. Finally, Robert W. Baird upped their price objective on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research note on Friday, July 19th. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Danaher presently has an average rating of “Buy” and a consensus price target of $145.92.
NYSE:DHR opened at $140.92 on Friday. The company has a market cap of $97.29 billion, a P/E ratio of 31.18, a P/E/G ratio of 2.27 and a beta of 0.94. The stock’s fifty day moving average price is $141.08 and its two-hundred day moving average price is $137.31. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $147.33. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91.
Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.15 earnings per share. On average, analysts expect that Danaher Co. will post 4.79 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, September 26th. This represents a $0.68 annualized dividend and a dividend yield of 0.48%. Danaher’s dividend payout ratio is currently 15.04%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Featured Story: Why do companies issue convertible shares?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.